Ardx marketwatch.

Ardelyx, Inc. Reports Employment Inducement Grants. WALTHAM, Mass., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that on December 18, 2023 ...

Ardx marketwatch. Things To Know About Ardx marketwatch.

View the latest Ardelyx Inc. (ARDX) stock price, news, historical charts, analyst ratings and financial information from WSJ.According to the issued ratings of 9 analysts in the last year, the consensus rating for Ardelyx stock is Buy based on the current 8 buy ratings and 1 strong buy rating for ARDX. The average twelve-month price prediction for Ardelyx is $12.81 with a high price target of $15.00 and a low price target of $8.50. Learn more on ARDX's analyst rating ...AXTI $3.66. 20.79% 0.63 · SPT $34.04. -29.30% -14.11 · ARDX $8.05. 18.55% 1.26 · Access Premium Tools. Search Clear. Search. Advanced Search. Search Results&nb...Ardelyx Inc. company facts, information and financial ratios from MarketWatch.

Nov 17, 2022 · Shares of Ardelyx Inc. rocketed 75.4% on heavy volume toward a 16-month high in premarket trading Thursday, after an advisory panel of the U.S. Food and Drug Administration voted that benefits of ...

Analysts Offer Insights on Healthcare Companies: Ardelyx (ARDX), Oric Pharmaceuticals (ORIC) and Cellectis SA (CLLS). May. 8, 2024 at 12:50 a.m. ET on ...

XNCR | Complete Xencor Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Ardelyx Inc. advanced stock charts by MarketWatch. View ARDX historial stock data and compare to other stocks and exchanges.3.12%. $374.65M. Reading International Inc. Cl A. -0.57%. $62.31M. AMC | Complete AMC Entertainment Holdings Inc. Cl A stock news by MarketWatch. View real-time stock prices and stock quotes for a ... Ardelyx Inc. company facts, information and financial ratios from MarketWatch. AMDL | A complete GraniteShares 2x Long AMD Daily ETF exchange traded fund overview by MarketWatch. View the latest ETF prices and news for better ETF ...

Read more on 'MarketWatch' Indices Commodities Currencies Stocks

ARDX Strong upgrade from a top financial firm ARDX Ardelyx is a biopharmaceutical company that discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the US and internationally. On 3/2/2022 Jefferies Financial Group Upgraded ARDX from Hold to Buy raising the price target from $1.00 to $.

According to the issued ratings of 9 analysts in the last year, the consensus rating for Ardelyx stock is Buy based on the current 8 buy ratings and 1 strong buy rating for ARDX. The average twelve-month price prediction for Ardelyx is $12.81 with a high price target of $15.00 and a low price target of $8.50. Learn more on ARDX's analyst rating ...3.61%. HK$67.05B. Inovio Pharmaceuticals Inc. -4.74%. $275.91M. NVAX | Complete Novavax Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Ardelyx (ARDX). (Real Time Quote from BATS). $7.96 ... Ardelyx (ARDX) Quote Overview » More Research » Ardelyx (ARDX) ... Marketwatch; Nasdaq; Forbes; Investors.com ...SPX | A complete S&P 500 Index index overview by MarketWatch. View stock market news, stock market data and trading information.688717 | Complete SolaX Power Network Technology (Zhejiang) Co. Ltd. A stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

ARDS | Complete Aridis Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Ardelyx Inc. company facts, information and financial ratios from MarketWatch. Ardelyx Inc. SEC filings breakout by MarketWatch. View the ARDX U.S. Securities and Exchange Commission reporting information. ADTX | Complete Aditxt Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.ARDX stock closed at $5.91 and is up $0.24 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. ARDX has a strong overall score of 86 meaning the stock holds a better value than 86% of stocks at its current price. InvestorsObserver's ...Nike Inc. Cl B. $90.94. -2.45. -2.62%. DJIA | A complete Dow Jones Industrial Average index overview by MarketWatch. View stock market news, stock market data and trading information. About Real-Time Quotes. Nasdaq provides NLS Volume, Previous Close, Today's High & Low, and the 52 week High & Low. The intraday chart, the last-five real-time quotes and sales data. Real-time ...

Ardelyx Inc. company facts, information and financial ratios from MarketWatch.

Ardelyx Inc. company facts, information and financial ratios from MarketWatch.Ardelyx Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ARDX updated stock price target summary.May 6, 2024 · After-Hours Trades. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as ... Nkarta stock price target cut to $21 from $38 at Stifel Nicolaus. Mar. 17, 2023 at 6:52 a.m. ETby Tomi Kilgore.Ardelyx Inc. options data by MarketWatch. View ARDX option chain data and pricing information for given maturity periods.MarketWatch provides the latest stock market, financial and business news. Get stock market quotes, personal finance advice, company news and more.Ardelyx Inc. company facts, information and financial ratios from MarketWatch. Ardelyx Inc. Annual stock financials by MarketWatch. View the latest ARDX financial statements, income statements and financial ratios.

VRTX | Complete Vertex Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Ardelyx Inc. ARDX, -0.94% stock is up 5.2% in premarket trades on Thursday after the Waltham, Mass., biopharmaceutical company said the U.S. Food and Drug Administration granted an appeal for its ...

Nov 17, 2022 · Shares of Ardelyx Inc. rocketed 75.4% on heavy volume toward a 16-month high in premarket trading Thursday, after an advisory panel of the U.S. Food and Drug Administration voted that benefits of ... ARDS | Complete Aridis Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.WALTHAM, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class ...Shares of Ardelyx Inc. ARDX, +1.74% soared 27.2% on massive volume in midday trading Wednesday, and have now nearly doubled in two days since the company announced plans to launch its treatment ...New York Community Bancorp Inc. $4.06. 1.89M. 0.17. 4.36%. Monitor leaders, laggards and most active stocks during after-market hours trading.Ardelyx Inc. company facts, information and financial ratios from MarketWatch.See Ardelyx, Inc. (ARDX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Ardelyx Inc. (NAS : ARDX) 9:50 PM ET. most recent headlines. All News Headlines. News Headlines for Ardelyx Inc. Monday, Dec 18, 2023. ... Ardelyx shares climb as kidney-disease drug gets green light from Japanese regulators MarketWatch. 08:06 AM ET. Friday, Mar 03, 2023. Ardelyx upgraded to outperform from neutral at Wedbush …VERU | Complete Veru Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.ARGX | A complete ARGX overview by MarketWatch. View the latest market news and prices, and trading information.At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

New York Community Bancorp Inc. $4.06. 1.89M. 0.17. 4.36%. Monitor leaders, laggards and most active stocks during after-market hours trading.ARDX. Value-focused investors are always on the hunt for stocks that are priced below their intrinsic value. One such stock that merits attention is Ardelyx Inc ( NASDAQ:ARDX ). The stock, which ...Ardelyx (ARDX) gets FDA approval for Xphozah to reduce serum phosphorus in adult patients with kidney disease on dialysis as an add-on therapy. The stock of the company climbs 13%.Instagram:https://instagram. latrobe bulletin latrobe pacarrabba's wesley chapel flusps in transit to next facilityfive nights at freddy's maps Bank of Nova Scotia. $63.30. -0.38. -0.60%. SPTSE | A complete S&P/TSX 60 Index index overview by MarketWatch. View stock market news, stock market data and trading information.2:00 pm. Monthly U.S. federal budget. April. $225B. -$236B. The median forecasts in this calendar come from surveys of economists conducted by Dow Jones Newswires and The Wall Street Journal. All ... jack begleyhiatal hernia repair cpt code Read more on 'MarketWatch' Indices Commodities Currencies Stocks esterly's sandwich shop AMRX | Complete Amneal Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Ardelyx Inc. Annual balance sheet by MarketWatch. View all ARDX assets, cash, debt, liabilities, shareholder equity and investments.